Literature DB >> 15753642

Pulmonary hypertension in men with thyrotoxicosis.

Ardeshir Soroush-Yari1, Samuel Burstein, Guy W Soo Hoo, Silverio M Santiago.   

Abstract

Thyrotoxicosis has a myriad of respiratory symptoms including dyspnea. Pulmonary hypertension may contribute to the respiratory symptoms of thyrotoxicosis, but is often unrecognized. We describe 3 male patients with thyrotoxicosis and associated pulmonary hypertension. Case reports of an additional 15 patients are also reviewed. In patients with thyrotoxicosis and pulmonary hypertension, treatment of thyrotoxicosis alone is associated with improvement in pulmonary hypertension. Previous reports have consisted of mostly female patients, but we report 3 men. When all cases are considered, the typical patient is female (10/14 = 71%), middle-aged (48 years), with mean pulmonary artery systolic pressures improving from 56 to 32 mm Hg with treatment. Autoantibodies were detected in 10/14 (71%) patients. The response to treatment (medical or surgical) of thyrotoxicosis supports the hypothesis that hyperthyroidism is either a cause of pulmonary hypertension, or a factor that may unmask pulmonary hypertension. Recognition is important since treatment and response are very different compared to other patients with pulmonary hypertension. This association may not be readily considered in men, since most reports have been of women. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753642     DOI: 10.1159/000083408

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

Review 1.  Pulmonary hypertension in thyroid diseases.

Authors:  Pietro Scicchitano; Ilaria Dentamaro; Francesco Tunzi; Gabriella Ricci; Santa Carbonara; Fiorella Devito; Annapaola Zito; Anna Ciampolillo; Marco Matteo Ciccone
Journal:  Endocrine       Date:  2016-03-19       Impact factor: 3.633

Review 2.  Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?

Authors:  Jason Weatherald; Laurent Savale; Marc Humbert
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

3.  Impact of achieving euthyroidism on pulmonary artery systolic pressures in hyperthyroidism-associated pulmonary hypertension - a systematic review.

Authors:  Shireen R Chacko; Pradhum Ram; Tamaryn Fox; Naveen Sooknanan; Kevin Bryan Lo; Ritesh G Menezes; Savita Lasrado; Glenn Eiger; Anjali Vaidya
Journal:  Am J Cardiovasc Dis       Date:  2022-08-15

4.  Atypical clinical manifestations of graves' disease: an analysis in depth.

Authors:  Mohamed Osama Hegazi; Sherif Ahmed
Journal:  J Thyroid Res       Date:  2011-11-01

5.  Reversible pulmonary hypertension and isolated right-sided heart failure associated with hyperthyroidism.

Authors:  Hassan M Ismail
Journal:  J Gen Intern Med       Date:  2007-01       Impact factor: 5.128

6.  Right ventricular dysfunction and pulmonary hypertension: a neglected presentation of thyrotoxicosis.

Authors:  Carolina Shalini Singarayar; Foo Siew Hui; Nicholas Cheong; Goay Swee En
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-05-16

7.  Isolated pulmonary arterial hypertension-janus' faces of hyperthyroidism.

Authors:  Beodeul Kang; Deok-Kyu Cho; Ki Hyun Byun; Lucy Youngmin Eun; Yun-Hyeong Cho
Journal:  Korean Circ J       Date:  2009-04-28       Impact factor: 3.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.